Asia Healthcare Industry Digest
SEE OTHER BRANDS

The latest healthcare and wellness news from Asia and the Pacific

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on June 27, 2025

Avalue Unveils Full-Spectrum AI Healthcare Solutions at International Modern Hospital Show 2025

Avalue Unveils Full-Spectrum AI Healthcare Solutions at International Modern Hospital Show 2025

TOKYO, JAPAN, June 27, 2025 /⁨EINPresswire.com⁩/ -- Avalue Technology Inc. (TPEx: 3479.TWO), a global leader in industrial computing solutions, will participate in International Modern Hospital Show 2025 in Tokyo, Japan (Booth 162), where it will showcase …

Sanjoo Sharma’s Inspiring Journey from a Humble Childhood to ₹500 Crore Business

Sanjoo Sharma’s Inspiring Journey from a Humble Childhood to ₹500 Crore Business

GURUGRAM, HARYANA, INDIA, June 27, 2025 /⁨EINPresswire.com⁩/ -- There are many layers to a success story and there is a moment or a phase of life where it starts. For Sanjoo Sharma, the visionary behind the Radical Minds Group, the journey dates back to …

Ultrasonic Position Sensor Market to Observe Strong Development by 2032

Ultrasonic Position Sensor Market to Observe Strong Development by 2032

Ultrasonic Position Sensor Market Expected to Reach $140.9 Million by 2032 WILMINGTON, DE, UNITED STATES, June 27, 2025 /⁨EINPresswire.com⁩/ -- The global ultrasonic position sensor market share is expected to witness considerable growth, owing to the …

Dr. Mohana Rao Patibandla Unveils Groundbreaking Neuroendoport Study at NSI YNF Conference

Dr. Mohana Rao Patibandla Unveils Groundbreaking Neuroendoport Study at NSI YNF Conference

Dr. Mohana Rao Patibandla Unveils Groundbreaking Neuroendoport Study at NSI YNF Conference GUNTUR, ANDHRA PRADESH, INDIA, June 27, 2025 /⁨EINPresswire.com⁩/ -- Dr. Mohana Rao Patibandla Unveils Groundbreaking Neuroendoport Study at NSI Conference …

Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities

Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities

FOR IMMEDIATE RELEASE Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities Paris, France —27, June, 2025— Orphalan SA, a global pharmaceutical company focused on rare …

Tilray Medical veröffentlicht bahnbrechende Forschungsergebnisse zur Pharmakokinetik von THC- und CBD-Formulierungen

Tilray Medical veröffentlicht bahnbrechende Forschungsergebnisse zur Pharmakokinetik von THC- und CBD-Formulierungen

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray” oder das „Unternehmen”) (Nasdaq: TLRY; TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische …

Tilray Medical publie une recherche pionnière sur la pharmacocinétique des formulations de THC et de CBD

Tilray Medical publie une recherche pionnière sur la pharmacocinétique des formulations de THC et de CBD

NEW YORK, 27 juin 2025 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray » ou la « Société ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis thérapeutique, qui favorise l’alliance thérapeutique entre les patients …

Biocon Biologics Receives Health Canada Approval for Yesafili™ (aflibercept); First Global Launch Scheduled for July 2025

Biocon Biologics Receives Health Canada Approval for Yesafili™ (aflibercept); First Global Launch Scheduled for July 2025

TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), is pleased to announce …

Kymera Therapeutics Announces Pricing of $250 Million Public Offering

Kymera Therapeutics Announces Pricing of $250 Million Public Offering

WATERTOWN, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing …

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service